Podcast: KHN’s ‘What The Health?’ Drug Prices Are Rising Again. Is Someone Going To Do Something About It?

As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court’s abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues.

Call The Midwife! (If The Doctor Doesn’t Object)

Hospitals and medical practices are battling outdated stereotypes and sometimes their own doctors to hire certified nurse midwives. Research shows that women cared for by certified nurse midwives have fewer cesarean sections, which can produce significant cost savings for hospitals.

Providers Walk ‘Fine Line’ Between Informing And Scaring Immigrant Patients

Some doctors and clinics are proactively informing patients about a proposed policy that could jeopardize the legal status of immigrants who use public benefit programs such as Medicaid. Others argue that because this “public charge” proposal isn’t final — and may never be adopted — disseminating too much information could create unnecessary alarm and cause some patients to drop benefits.

To Get Mental Health Help For A Child, Desperate Parents Relinquish Custody

To get care for their 12-year-old son’s severe mental illness, Toni and Jim Hoy had to give up custody of him and allow the state of Illinois to care for him. It happens to hundreds, perhaps thousands of children each year. The exact number is unknown because two-thirds of states do not keep track.

When Medicine Makes Patients Sicker

The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents — inspection records, recalls, warning letters and lawsuits — reveals how drugs that are poorly manufactured or contaminated can reach consumers.